𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Lipid lowering treatment with bezafibrate in patients on chronic haemodialysis: Pharmacokinetics and effects

✍ Scribed by Grützmacher, P. ;Scheuermann, E. -H. ;Siede, W. ;Lang, P. D. ;Abshagen, U. ;Radtke, H. W. ;Baldamus, C. A. ;Schoeppe, W.

Publisher
Springer-Verlag
Year
1986
Tongue
English
Weight
585 KB
Volume
64
Category
Article
ISSN
1432-1440

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Oral pharmacokinetics of pirenzepine in
Oral pharmacokinetics of pirenzepine in patients with chronic renal insufficiency, failure, and maintenance haemodialysis
✍ T. MacGregor; K. Matzek; J. Keirns; M. Vinocur; A. Chonko 📂 Article 📅 1990 🏛 Springer 🌐 English ⚖ 215 KB

The pharmacokinetic properties of pirenzepine following administration of a single, 50 mg oral dose were evaluated in three groups of subjects: group I, end stage renal disease requiring maintenance haemodialysis (CLCR 0 to 10 ml.min-1); group II, moderate renal insufficiency (CLCR 10 to 30 ml.min-1